OncoZenge AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Apr '26 Apr 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020
Market Capitalization	87	85	44	36	64	135	Upgrade
Market Cap Growth	65.36%	94.64%	21.36%	-43.82%	-52.42%	-	Upgrade
Enterprise Value	90	81	38	20	32	80	Upgrade
Last Close Price	6.17	6.76	3.75	3.09	5.50	11.56	Upgrade
PS Ratio	31.13	30.71	43924.67	12064.64	-	-	Upgrade
PB Ratio	10.22	10.09	4.42	1.94	1.90	1.69	Upgrade
P/TBV Ratio	53.27	52.55	14.17	3.07	2.38	1.84	Upgrade
EV/Sales Ratio	32.49	29.24	38094.67	6750.97	-	-	Upgrade
EV/EBITDA Ratio	-	-	-	2.79	11.43	-	Upgrade
Debt / Equity Ratio	0.89	0.89	-	-	-	-	Upgrade
Net Debt / Equity Ratio	0.45	0.45	-0.39	-0.68	-0.86	-0.64	Upgrade
Net Debt / EBITDA Ratio	-	-	-	-1.74	-10.53	-	Upgrade
Asset Turnover	0.16	0.16	0	0	-	-	Upgrade
Quick Ratio	0.74	0.74	2.95	7.81	10.22	10.62	Upgrade
Current Ratio	1.01	1.01	3.09	7.94	10.29	10.63	Upgrade
Return on Equity (ROE)	-173.01%	-173.01%	-60.77%	-60.45%	-81.62%	-7.09%	Upgrade
Return on Assets (ROA)	-55.07%	-55.07%	-34.17%	-34.73%	-20.88%	-4.95%	Upgrade
Return on Capital Employed (ROCE)	-98.80%	-98.80%	-87.30%	-85.30%	-60.10%	-6.10%	Upgrade
Earnings Yield	-18.39%	-18.64%	-19.78%	-43.94%	-72.41%	-2.87%	Upgrade
Buyback Yield / Dilution	-3.56%	-3.56%	-	-	0.53%	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.